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Antibiotic resistance is a pressing global health problem that threatens millions of
lives each year. Natural antimicrobial peptides and their synthetic derivatives, including
peptoids and peptidomimetics, are promising candidates as novel antibiotics. Recently,
the C-terminal glycine-rich fragments of human epithelial keratin 6A were found to have
bactericidal and cytoprotective activities. Here, we used an improved 2-dimensional
NMR method coupled with a new protocol for structural refinement by low temperature
simulated annealing to characterize the solution structure of these kerain-derived
antimicrobial peptides (KAMPs). Two specific KAMPs in complex with membrane
mimicking sodium dodecyl sulfate (SDS) micelles displayed amphipathic conformations
with only local bends and turns, and a central 10-residue glycine-rich hydrophobic strip
that is central to bactericidal activity. To our knowledge, this is the first report of non-αβ
structure for human antimicrobial peptides. Direct observation of Staphylococcus aureus
and Pseudomonas aeruginosa by scanning and transmission electron microscopy
showed that KAMPs deformed bacterial cell envelopes and induced pore formation.
Notably, in competitive binding experiments, KAMPs demonstrated binding affinities to
LPS and LTA that did not correlate with their bactericidal activities, suggesting peptide-
LPS and peptide-LTA interactions are less important in their mechanisms of action.
Moreover, immunoprecipitation of KAMPs-bacterial factor complexes indicated that
membrane surface lipoprotein SlyB and intracellular machineries NQR sodium pump
and ribosomes are potential molecular targets for the peptides. Results of this study
improve our understanding of the bactericidal function of epithelial cytokeratin fragments,
and highlight an unexplored class of human antimicrobial peptides, which may serve as
non-αβ peptide scaffolds for the design of novel peptide-based antibiotics.
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INTRODUCTION
Antimicrobial resistance is a major public health problem
posing deadly threats to the global community. Bacterial
infections caused by common pathogens, such as Escherichia
coli, Pseudomonas aeruginosa, Acinetobacter baumannii,
Staphylococcus aureus, and Streptococcus pneumoniae, are
becoming extremely difficult to treat with current antibiotics
(Thabit et al., 2015). Each year hundreds of thousands of
people around the world die from infections caused by
multidrug-resistant organisms (O’Neill, 2016). Novel classes of
anti-infective therapeutics are urgently needed to curtail further
deterioration of the situation.
Our skin and mucosal surfaces are under constant challenge
by pathogenic microbes in the environment. Production of
antimicrobial peptides (AMPs) by epithelial cells and local
phagocytes provides a crucial innate defense mechanism
guarding the host barriers against microbial invasion. Indeed
they are produced by virtually all organisms from bacteria to
vertebrates and are best known for their direct and fast-acting
microbicidal activity (http://aps.unmc.edu/AP) (Wang et al.,
2016). These host defense peptides, primarily defensins and
cathelicidins, are short (12-50 amino acids), polycationic,
amphipathic peptides possessing α-helical and/or β-sheet
structures critical for their antimicrobial activities (Wang,
2014). Furthermore, accumulating evidence has shown the
multifaceted contributions of AMPs beyond direct killing of
microbes, including modulation of inflammatory responses
(Zhang and Gallo, 2016) and promotion of epithelial migration
and angiogenesis during wound healing (Mangoni et al., 2016).
With advanced technologies in synthesis, functional design
and modification of synthetic analogs, cationic AMPs and
their modified derivatives are being recognized as promising
anti-infective candidates, including six compounds currently in
phase I-III clinical trials (Fox, 2013).
Keratins are a large family of intermediate filament
proteins comprising the epithelial cell cytoskeleton. Obligate
heterodimers and -tetramers of type I keratins (K9-K10,
K12-K28, K31-K40) and type II keratins (K1-K8, K71-86) in
the cytosol assemble and form a dynamic filament network
that remodels upon mechanical, metabolic, and oxidative
stresses to preserve the integrity of cell structure and function.
Recently, a series of overlapping fragments derived from
the C-terminal region (a.a. 515-559) of human K6A were
found to be bactericidal (Tam et al., 2012). K6A is a type II
keratin constitutively expressed in many types of stratified
epithelial cells (Moll et al., 1982) and is upregulated in
response to cytokines during inflammation and tissue injury
(Coulombe et al., 2004). These glycine-rich human K6A-
derived antimicrobial peptides (KAMPs, previously known as
KDAMPs) are not constrained by their modest net charge (0
to +2), low helical content (determined by circular dichroism
(CD) spectroscopy), or the high salt concentration of the
environment, unlike canonical antimicrobial peptides (Tam
et al., 2012). In addition, KAMP treatment effectively protects
cultured human corneal epithelial cells from bacteria-induced
cytotoxicity and bacterial invasion without impacting the
morphology and viability of the epithelial cells (Tam et al.,
2012).
Here we investigated four KAMP members (Table 1), one
of which (KAMP-10) has a net charge of zero (no basic
amino acids Lys and Arg) to better understand the structural
and mechanistic features of KAMPs. An improved solution
nuclear magnetic resonance (NMR) spectroscopy method
coupled with low temperature simulated annealing was used to
obtain high-quality 3D structure of KAMPs in SDS micelles.
While anionic detergent and lipid micelles are both essential
mimetic systems of bacterial membranes in solution NMR
to obtain high-resolution spectra for structure determination,
it has been demonstrated that the 3D structures of human
cathelicidin LL-37 and its fragments in complexes with SDS
micelles can be applied to their phosphatidylglycerol (PG)-
and lipopolysaccharides (LPS)-bound states (Wang, 2008; Wang
et al., 2012). In this study, we showed that SDS micelle-
bound KAMPs are largely extended without typical α-helix
or β-sheet structures, consistent with the structure in the
presence of large unilamellar liposomes determined by CD
spectroscopy. Mechanistically, peptide binding to the two major
bacterial membrane components, LPS and lipoteichoic acid
(LTA), is not key to the bactericidal function of KAMPs. Both
scanning electron microscopy (SEM) and transmission electron
microscopy (TEM) showed dose-dependent disruptive effects of
KAMPs on bacterial cell envelopes. While other mechanisms
might also be involved, we used co-immunoprecipitation
to identify SlyB lipoprotein as a potential bacterial surface
ligand during peptide-membrane interactions, and NqrA and
ribosomes as potential intracellular targets. Given that the
majority of characterized AMPs, as well as all human AMPs
to date belong to cationic α, β, or αβ classes (Wang,
2014), this study identifies the first human AMPs with
a non-αβ structure, and contributes to the knowledge of
unconventional AMPs, especially those that do not rely on
defined α-helical or β-sheet structures to facilitate interactions
with anionic bacterial membranes and subsequent membrane
perturbation.
MATERIALS AND METHODS
Bacterial Strains
Pseudomonas aeruginosa corneal isolate 6206 provided by
Suzanne M. J. Fleiszig (School of Optometry, University of
California, Berkeley, USA), and S. aureus 29213 fromATCCwere
used in this study.
Peptide Synthesis
All peptides used in this study were synthesized by American
Peptide Company (now Bachem Americas, Torrance, CA) at
>95% purity. Their sequences and net charges were shown in
Table 1. Peptide content, purity and sequence were confirmed by
amino acid analysis, HPLC and electrospray mass spectrometry.
Stock solutions were prepared in sterile distilled water and stored
at−20◦C. Aliquots were limited to one thaw prior to use.
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TABLE 1 | Amino acid sequences of the KAMPs used in this study.
Peptide hK6A (NP_005545) a.a. Sequence Net Charge (pH 7.0) Pho% Boman index (kcal/mol)
KAMP-10 537–546 GGLSSVGGGS 0 20 −0.34
KAMP-18C 533–550 RAIGGGLSSVGGGSSTIK +2 27 0.57
KAMP-19 533–551 RAIGGGLSSVGGGSSTIKY +2 26 0.55
KAMP-36 517–552 YGSGLGVGGGFSSSSGRAIGGGLSSVGGGSSTIKYT +2 22 0.32
Percentage of hydrophobic amino acids (Pho%), net charge and Boman index (estimated protein-binding potential) of each peptide are calculated using the APD website (Wang et al.,
2016). KAMP-18C and KAMP-19 have similar Boman indexes, while shorter and longer peptides have reduced protein binding potential.
Preparation of Liposomes
Lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
(POPE), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-
rac-glycerol) (POPG), and 1,2-dielaidoyl-sn-glycero-3-
phosphoethanolamine (DEPE) were purchased from Avanti
Polar Lipids in chloroform solution. Gel filtration-purified
P. aeruginosa LPS was purchased from Sigma-Aldrich and
reconstituted in distilled water. The large unilamella liposomes
were prepared by the freeze-thaw and extrusion method as
previously described (Ouberai et al., 2011). Briefly, lipids (1mg
total) in chloroform were evaporated under a dry nitrogen
stream to yield a lipid film, then hydrated and vigorously
agitated for 2 h with 1ml of pre-warmed 0.9% saline at 35◦C for
POPE/POPG liposomes, or with 1ml of pre-warmed 0.9% saline
containing 600µg P. aeruginosa LPS at 45◦C for LPS/DEPE
liposomes. The liposomal suspensions were subjected to 6 freeze-
thaw cycles and 10 passes of extrusion through two stacked
polycarbonate membranes with a pore size of 100 nm (Whatman
Nuclepore) at 35◦C for POPE/POPG liposomes or at 45◦C for
LPS/DEPE liposomes. The size and monodispersity of liposomes
were confirmed by dynamic light scattering with a Zetasizer
Nano-ZS (Malvern Instruments). The liposome concentration,
represented by total phosphorous content, was quantified by the
Barlett assay (Torchilin and Weissig, 2003).
Particle Size and Surface Charge
Characterization
Zetasizer Nano-ZS (Malvern Instruments) with an incident beam
of He-Ne ion laser (λ = 633 nm) and a 173◦ detection angle
was used to measure particle size dimensions and zeta potentials
of peptides, SDS micelles, liposomes, or peptide-associated
SDS micelles/liposomes. For the peptide-SDS mixtures, SDS
concentration was fixed at 10mM in water, while peptide
concentrations were varied from 21 to 167 µM to achieve 1:480,
1:240, 1:120, and 1:60 peptide-to-SDS molar ratios. For the
peptide-liposome mixtures, lipid concentration was fixed at 30
µM in saline, while peptide concentrations were varied from
3.75 to 240 µM to achieve 1:8, 1:4, 1:1, 4:1, or 8:1 peptide-to-
lipid molar ratios. Each sample had a volume of 700 µl and
was transferred into a low volume disposable sizing cuvette
for particle size measurement or a folded capillary cell for
zeta potential measurement. The samples were characterized
immediately after preparation at 25◦C. Each measurement was
made in triplicate. Cumulant method and the Stokes-Einstein
equation were used to calculate the hydrodynamic diameters
(volume average) of particles. The Smoluchowski equation was
applied to electrophoretic mobility data to determine zeta
potentials.
CD Spectroscopy
CD spectra were acquired at 25◦C in a 1.0-mm path-length
quartz cell with a Jasco J-815 CD spectropolarimeter. Peptide
stocks were diluted in distilled water added to solutions of SDS
(2–10mM in distilled water) or liposomes (0.25–1mM in 0.9%
saline) to obtain a final peptide concentration of 0.1mM. Each
sample was measured immediately after preparation or 24 h post-
incubation at 4◦C. All samples were scanned from 260 to 195 nm
at an interval of 0.1 nm. Spectra were background-subtracted and
converted to mean residue molar ellipticity.
NMR Spectroscopy
NMR spectra were acquired at 298K with a Bruker Biospin
Avance II 900MHz spectrometer equipped with a TCI cryoprobe
at the California Institute for Quantitative Biomedical Research
(QB3), University of California, Berkeley. NMR samples
containing 3.4mM KAMP-10 or KAMP-19 in 0.2 M deuterated
SDS (Sigma-Aldrich), 1 mM DSS and 10% D2O with an
unadjusted pH of 4.5 were prepared and placed in 5 mm
NMR tubes (Norell). Two-dimensional DQF-COSY, TOCSY,
NOESY and HSQC-TOCSY experiments were conducted and
processed with the TopSpin package (Bruker Biospin) for
backbone assignment. The mixing times for TOCSY and NOESY
experiments were set to 100 ms and 500 ms respectively.
Chemical shifts were referenced against DSS. Secondary
structural elements were determined by Hα secondary shift
analysis. In addition, another set of NMR spectra, including
heteronuclear 15N and 13C 2D correlated spectra under natural
abundance, were collected on a 600 MHz Varian NMR
spectrometer, processed and analyzed as described previously
(Wang, 2008).
Structural Calculations
For structural determination, distance restraints were obtained
from two-dimensional NOESY spectra (mixing time 150ms).
The cross peaks were integrated by PIPP (Garrett et al., 1991)
and converted to distance restraints 1.8–2.8, 1.8–3.8, 1.8–5.0,
and 1.8–6.0 Å corresponding to strong, medium, weak, and very
weak types of NOE peaks, respectively. Based on 1Hα, 15N,
13Cα, and 13Cβ chemical shifts, backbone angles of micelle-
bound peptide were predicted by using an updated version
of TALOS (Shen et al., 2009). An extended covalent structure
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was used as starting coordinates. An ensemble of structures
was calculated by using the simulated annealing protocol in
the Xplor-NIH program (Schwieters et al., 2003). In all the
structures, the polypeptide chain was largely extended with
local packing only. In the second round of calculations, a low
temperature simulated annealing was conducted at an initial
temperature 200K and high temperature 500K with 500 cooling
steps to generate a structural ensemble that satisfies all the
NMR restraints. Structures were accepted based on the following
criteria: no NOE-derived distance violations greater than 0.30
Å, backbone dihedral angle violations less than 3◦, root mean
standard deviations (r.m.s.d.) for bond deviations from ideality
less than 0.01 Å, and r.m.s.d. for angle deviations from ideality
less than 5◦. The structures were viewed and analyzed using
PROCHECK (Laskowski et al., 1996) and MOLMOL (Koradi
et al., 1996). Structural data were deposited in the Protein Data
Bank (PDB ID 5KI0).
Scanning Electron Microscopy
Log-phase P. aeruginosa or S. aureus [200 µl of 108 CFU/ml
in saline supplemented with 1% Keratinocyte Basal Medium
(Lonza)] were incubated with 0, 45 and 60 µg/ml of KAMP-
10 or 0, 60 150 µg/ml of KAMP-18C respectively at 37◦C for
3 h. Bacteria were pelleted at 5000 g for 5min, resuspended in
2.5% glutaraldehyde in PBS and deposited onto a 0.4 µm-pore-
size polycarbonate membrane (Whatman Nuclepore) for 1 h
at room temperature then 4◦C overnight, then post-fixed with
1% osmium tetroxide (OsO4) for 1 h, 1% thiocarbohydrazide
(TCH) for 5min, and 1% OsO4 again for 5min (Willingham
and Rutherford, 1984). After post-fixation, samples were
dehydrated with graded ethanol series, then impregnated with
50% hexamethyldisilazane (HMDS) in ethanol, and finally 100%
HMDS. The air-dried samples were sputtered with gold before
imaging. SEM images were taken with FEI Helios Nanolab 650 at
the Swagelok Center for Surface Analysis of Materials (SCSAM)
at Case Western Reserve University.
Transmission Electron Microscopy (TEM)
Log-phase bacteria (108 CFU/ml; 1ml) were treated with KAMPs
for 3 h as described in the SEM section. Treated bacteria
were pelleted, then fixed with triple aldehyde-DMSO (Fujioka
et al., 2012) for 30min at room temperature. The bacteria
were then rinsed with 0.1 M HEPES buffer (pH 7.3) and
post-fixed with ferrocyanide-reduced OsO4 before embedding.
Thin sections were sequentially stained with acidified 2% uranyl
acetate followed by a modification of Sato’s triple lead stain
(Hanaichi et al., 1986). TEM images were taken at the Electron
Microscopy Core Facility, School of Medicine, Case Western
Reserve University using FEI Tecnai Spirit (T12) with a Gatan
US4000 4k× 4k CCD.
Competitive Binding Assay
BODIPY-TR-cadaverine (Life Technologies) was prepared in
10mMNaCl or 5mMHEPES (pH 7.5) and pre-warmed at 37◦C.
Purified P. aeruginosa LPS and S. aureus LTA (Sigma-Aldrich)
were prepared in distilled water. Colistin and meropenem
(Santa Cruz Biotechnology) were used as positive and negative
controls respectively (Ouberai et al., 2011). A final 100 µl
mixture of 5 µM BODIPY-TR-cadaverine (in 10mM NaCl or
5mM HEPES, pH 7.5), 15 µg/ml LPS or LTA, and peptides
or antibiotics in a concentration ranged from 0.02 to 272 µM
was added to a 96-well black assay plate. The fluorescence
at 580/620 nm was measured at 37◦C with a Synergy 4
fluorescence microplate reader (BioTek). Displacement
percentage of KAMP relative to colistin and meropenem
was determined by: fluorescence of (probe/endotoxin/KAMP
mixture - probe/endotoxin/meropenem mixture) / fluorescence
of (probe/endotoxin/colistin mixture - probe/endotoxin/
meropenem mixture)× 100%.
Antibacterial Activity Assay
Lawn culture of P. aeruginosa was grown on tryptic soy agar
plates at 37◦C for 16 h. Starting inoculum at a concentration of
108 CFU/ml was prepared by suspending the bacteria in serum-
free Keratinocyte Basal Medium (Lonza) until OD650 reading
was approximately 0.1. The starting inoculum was diluted 100-
fold with 10 mM NaCl or 5 mM HEPES (pH 7.5) resulting
106 CFU/ml bacteria. Stock solution of peptides (or equivalent
volume of distilled water as no peptide control) was then added
to 106 CFU/ml bacteria and the final concentration of peptides
was 200 µg/ml. The mixtures were incubated at 37◦C for 3
h. The experiment was run in triplicate. Serial dilutions of the
samples at time 0 and 3 h were plated on tryptic soy agar plates
and incubated at 37◦C overnight for viable bacterial counts in
CFU/ml. The percentage killing was determined by: (bacterial
count without peptide - bacterial count with peptide) / bacterial
count without peptide× 100%.
Bacterial Fractionation and
Immunoprecipitation
P. aeruginosa was pelleted at 5000 g centrifugation for 20min,
then separated into periplasmic, cytoplasmic, inner membrane
and out membrane fractions as described previously (Thein
et al., 2010). The fractions were dialyzed against 10mM NaCl
overnight, and pre-cleared with Protein A/G resins for 1 h
at 4◦C with gentle rotation. Rabbit serum containing anti-
KAMP-19 antibody (custom made by New England Peptide)
(Tam et al., 2012) was covalently coupled to Protein A/G resin
(Santa Cruz Biotechnology) with the cross-linker BS3 (Thermo
Scientific) according to the manufacturer’s instructions. Pre-
cleared bacterial fraction (0.15–1mg protein) was mixed with or
without 80µg of KAMP-19 and incubated for 1 h at 4◦C with
gentle rotation. All the samples were immunoprecipitated with
35µl of anti-KAMP-19-coupled resins in a total volume of 400
µl for 2 h at 4◦C with gentle rotation. Resins were washed 5 times
with 10 mM NaCl, and eluted by heating for 5min with 40µl of
SDS loading buffer (Biorad) containing no reducing agent. The
eluates were supplemented with 62.5mM of DTT (Amresco) and
heated again for 5 min prior to 10% Tris-glycine SDS-PAGE. The
gel was treated with silver staining (Thermo Scientific).
Mass Spectrometry
Mass spectrometry was performed at the Lerner Research
Institute Proteomics Core at the Cleveland Clinic. Protein bands
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(within the areas where band patterns of IP and control were
different) were cut out from the gel and digested with trypsin
for LC-MS analysis. The LC-MS system used was a Finnigan
LTQ-Obitrap Elite hybrid mass spectrometer system. The HPLC
column was a Dionex 15 cm × 75 µm i.d. Acclaim Pepmap
C18, 2 µm, 100 Å reversed phase capillary chromatography
column. Five microliters volumes of the extract were injected
and the peptides eluted from the column by an acetonitrile/0.1%
formic acid gradient at a flow rate of 0.25 µl/min were
introduced into the source of the mass spectrometer on-line.
The microelectrospray ion source is operated at 2.5 kV. The
digest was analyzed using the data dependent multitask capability
of the instrument that acquired full scan mass spectra to
determine peptide molecular weights and product ion spectra to
determine amino acid sequence in successive instrument scans.
The data were analyzed by using all CID spectra collected in
the experiment to search the P. aeruginosa reference sequence
database with the programs Mascot and Sequest.
Statistical Analysis
Data are expressed as mean ± SD, calculated from triplicate
samples per group in each experiment. Each experiment was
performed individually at least three times. Statistical significance
of differences between 2 groups was determined by the Student’s
t-test (two-tailed). P < 0.05 was considered significant.
RESULTS
KAMPs Interact with Bacterial Membrane
Mimetics
SDS micelles, as well as large unilamellar liposomes are
commonly used models of membranous environments. The
zwitterionic phosphatidylethanolamine (PE) and the anioinc
phosphatidylglycerol (PG) are the major components of bacterial
plasma membranes (Warschawski et al., 2011). Therefore,
POPE/POPG have been used in numerous studies to mimic
bacterial cytoplasmic membranes of both Gram types. In
addition to PE, anionic LPS is a major structural component
of the outer membrane of Gram-negative bacteria. It has been
shown that LPS can be incorporated into DEPE membranes
without disturbing membrane morphology (Nomura et al.,
2011), rendering it a great model of bacterial outer membranes
(Su et al., 2011). To conduct an initial investigation of potential
interactions between KAMPs and bacterial membranes, we
employed the dynamic and electrophoretic light scattering
techniques to measure particle size distributions and zeta (ζ )
potentials of the membrane mimetics alone and mixed with
KAMPs (Domingues and Santos, 2010; Freire et al., 2011;
Naskar et al., 2013). As shown in Figures 1A, 2A,B, the average
volume hydrodynamic diameters of SDS micelles, LPS/DEPE
liposomes and POPE/POPG liposomes were 2.95 ± 0.09, 126.0
± 2.1 and 127.5 ± 2.7 nm respectively, indicating monomodal
size distribution with low polydispersity. High concentration
of KAMP-19 alone (167 µM) had two major particle size
populations with average volume hydrodynamic diameters of
∼50 and ∼400 nm (Figure 1B). It has been reported that
glycine and serine residues in transmembrane helices may
facilitate self-oligomerization (Smith et al., 2013). Upon addition
of KAMP-19 at various molar ratios (including the molar
ratio used in the subsequent 3D structural characterization by
NMR spectroscopy), hydrodynamic diameters of SDS micelles
increased (p < 0.005) (Figure 1C). Peptide-liposome complexes
also increased in size with increasing peptide-to-lipid (P/L)molar
ratios (Figures 2A,B). Specifically, at 8:1 (P/L) ratio, the average
volume hydrodynamic diameters of KAMP-19/LPS/DEPE and
KAMP-18C/POPE/POPG liposome complexes were found to be
161.4 ± 1.0 and 257.9 ± 18.2 nm respectively (p < 0.005).
With regard to the peptide effects on surface potential of
membrane mimetics, the magnitude of zeta potential for the
anionic SDS micelles was increased significantly (p < 0.01) in
the presence of KAMP-19 (Figure 1D), suggesting that DS−
monomers in the aqueous medium were drawn toward the
micelles by the positively charged KAMP-19 at the interface.
It has been reported that the hydrophobic portions of classic
amphipathic helices penetrate into the interior of SDS or
dioctanoylphosphatidylglycerol (D8PG) micelle cores, while the
cationic amino acids such as arginines directly interact with
the anionic headgroups (Wang et al., 1996; Wang, 2008). In
agreement with literature (Den Hertog et al., 2004; Ringstad
et al., 2006; Manzini et al., 2014), zeta potentials of anionic
LPS/DEPE liposomes (−16.07 ± 0.35 mV) and POPE/POPG
liposomes (−26.10 ± 0.66 mV) became less negative when they
were mixed with increasing concentration of cationic KAMP-19
and KAMP-18C respectively (Figures 2C,D), indicating surface
charge neutralization by KAMPs. The change of liposome zeta
potentials became significant when the molar ratios of peptide
to lipid were higher than 1:1. Specifically, at 4:1 and 8:1
(peptide/lipid) molar ratios, KAMP-19/LPS/DEPE complexes
exhibited zeta potentials of −13.77 ± 0.55 mV and −12.27 ±
0.87 mV respectively (p < 0.005), and KAMP-18C/POPE/POPG
complexes displayed −19.73 ± 0.59 mV and −16.40 ± 0.26 mV
(p< 0.0005). Collectively, the data indicated KAMP interactions
with both detergent and lipid membrane mimetics and validated
their application in the subsequent study of membrane-bound
structures of KAMPs.
CD Characterization of Peptide
Conformations in Complex with Bacterial
Membrane Mimetics
Regular conformations (i.e., α-helix, β-sheet) that are
amphipathic are essential for most AMPs to destabilize the
bacterial membrane. Previously, CD spectroscopy was used
to estimate the secondary structures of various KAMPs,
including KAMP-10 and KAMP-19, in aqueous (water) or
hydrophobic (2,2,2 trifluoroethanol) media, and no induced
helical conformations were found (Tam et al., 2012). Here,
to determine the conformations of KAMPs in complex with
bacterial cell model membranes, KAMP-19 and KAMP-10
were individually mixed with increasing concentration of SDS
micelles or LPS/DEPE liposomes and their CD spectra were
analyzed. KAMP-19 alone in distilled water (Figure 1E) or
saline (Figure 2E) displayed the characteristic CD spectrum
of random-coil as expected, which was indicated by strong
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FIGURE 1 | Volume-based particle size distributions, zeta potentials and circular dichroism spectra of KAMP/SDS micelle complexes. (A) SDS micelles
(10mM in water) are monomodal in size with hydrodynamic diameter of ∼3 nm. (B) KAMP-19 (167 µM in water, the concentration used in 1:60 peptide/SDS mixture
for (C) and (D)) showed two major populations of particle size with hydrodynamic diameters of ∼50 and ∼400 nm. After mixing with KAMP-19, (C) the particle sizes
and (D) the magnitudes of zeta potential of anionic SDS micelles were increased. (E) The CD spectrum of KAMP-19 in water showed unstructured random coil
conformation. Increasing the concentration of SDS did not change the overall random coil conformation. Similarly, (F) KAMP-10 remained random coil-like in the
presence of SDS. Increasing the concentration of SDS did not induce helical structure. Mean ± SD is shown. *p < 0.05, **p < 0.005 (t-test, two-tailed).
negative ellipticity at the 195–200 nm region and near-zero
ellipticity above 210 nm. Comparing with the signature CD
spectrum of α-helix which displays two negative troughs at
208 nm and 222 nm and a positive peak at 193 nm, the overall
conformations of KAMP-19 remained as random coils in the
presence of SDS micelles (Figure 1E) or LPS/DEPE liposomes
(Figure 2E), albeit the magnitude of ellipticity at the 195–200 nm
decreased suggesting a propensity for a more ordered structure.
Higher peptide-to-micelle or peptide-to-lipid ratios did not
make significant difference to the unstructured conformation
of KAMP-19. We also prolonged the incubation time prior
measurements to allow ample time for peptide interactions with
bacterial membrane mimetics, yet no induction of secondary
structure was observed (Figure 2F). A similar analysis was
conducted with KAMP-10 and the observations were consistent
(Figures 1F, 2G,H). Although a potential conformational
change in the case of KAMP-10 is not a clear cut as the case of
KAMP-19, these CD spectra indicated that KAMPs in complex
with biomembrane-like liposomes and with SDS micelles display
similar random coil conformations.
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FIGURE 2 | Volume-based particle size distributions, zeta potentials and circular dichroism spectra of KAMP/large unilamellar liposome complexes.
(A) LPS/DEPE liposomes (30 µM in saline) and (B) POPE/POPG liposomes (30 µM in saline) were monomodal in size. After mixing with KAMP-19 or KAMP-18C, the
particle size of (A) LPS/DEPE liposomes and (B) POPE/POPG liposomes increased. Anionic (C) LPS/DEPE liposomes and (D) POPE/POPG liposomes displayed less
negative zeta potential after positively charged KAMP-19 or KAMP-18C was added. (E) Immediately after mixing with LPS/DEPE liposomes, KAMP-19 showed
decreased magnitude of ellipticity without changing the overall random coil conformation. (F) Consistent observation was recorded after KAMP-19 had been
incubated with the liposomes for 24 h. Similarly, (G) ellipticity of KAMP-10 remained the same immediately after mixing with the liposomes. (H) Longer incubation time
(24 h) also did not make any difference. Mean ± SD is shown. **p < 0.005, ***p < 0.0005 (t-test, two-tailed).
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NMR Structures of KAMP-10 and KAMP-19
Bound to Membrane-Mimetic Micelles
To determine the structures of KAMPs at the atomic level, NMR
signal resonances were assigned using the established method
of Wüthrich (Wüthrich, 1986) based on two-dimensional DQF-
COSY, TOCSY, and NOESY experiments. As an example, the
proton assignments for the fingerprint regions of KAMP-10
and KAMP-19 in complex with SDS micelles are shown in
Figure 3A. The secondary Hα chemical shifts of KAMP-19 and
KAMP-10 in SDS micelles were calculated based on the random
chemical shifts of Wüthrich (Wüthrich, 1986) and presented in
Figure 3B. In this plot, a string of negative deviations (due to
up field shifts) suggests α-helical conformations, while a string
of positive shifts (due to down field shifts) implies β-strands.
However, these deviations are relatively small (mostly −0.15 or
less) and local compared to those of human cathelicidin LL-37
(mostly −0.2 to −0.7) bound to SDS (Wang, 2008). Thus, a
regular helical structure or β-stand is unlikely, consistent with
CD spectra (Figures 1E,F). However, we do not exclude a local
helical turn spanning residues Leu7-Ser9 in KAMP-19. This
helical turn appears to be conserved in KAMP-10 (residues Leu7-
Ser9) (Figure 3B). Indeed, structural calculations revealed such a
helical turn between residues 7–9 in KAMP-19.
To further refine the atomic structure of KAMP-19 in bacterial
membrane-mimetic environments, we used an improved 2D
NMR method, which includes the use of natural abundance
2D heteronuclear spectra (Wang et al., 2005). The importance
of this improved NMR method in spectral resolution and thus
the accuracy of structure determination has been demonstrated
recently (Wang, 2013). The NMR restraints used for structural
determination include 94 distance restraints and 18 backbone
dihedral angle (ψ and 8) restraints derived from chemical shift
analysis. Since there are no long-range NMR restraints and
the overall structure is largely extended, we also refined the
structure by using low temperature simulated annealing, from
which we generated a structural ensemble (Figure 3C). Analysis
of this structural ensemble revealed two one-turn 310 helices
between residues 7–9 and 15–17, indicating the structure is
largely extended with local bends and turns (Figure 3D). This
structure is unique because it differs from known structures of
human AMPs that consist of α-helix (e.g., LL-37), β-sheet (e.g.,
α-defensins), or mixed α and β structures (e.g., β-defensins)
(Wang, 2014). Furthermore, when the hydrophobic residues
are colored in green (including glycines in rasmol analysis),
a nearly continuous string of hydrophobic groups is revealed
(Figures 3E,F). Interestingly, the hydrophilic side chains are
sparse and only appear at the N-terminus (Arg1), center (Ser8
and Ser9), and C-terminus of the peptide chain (Ser-Ser-Thr
and Lys-Tyr) (Figures 3E,F). Therefore, the overall structure of
KAMP-19 is amphipathic. Such an amphipathic structure sheds
light on the molecular basis of membrane binding of KAMP-
19. In this structure, the C-terminal aromatic ring of Tyr19
is adjacent to the hydrophobic surface. This tyrosine may be
involved in membrane binding. There is precedent for such
a role of interfacial tyrosine bound to micelles (Wang et al.,
1996). In addition, basic side chains can also interact with
anionic membranes, especially when located in the interface
of the amphipathic structure (Wang, 2007). However, these
hydrophilic residues in KAMP-19 did not appear to be important
here because they are dispensable. KAMP-13, obtained after
removing the N-terminal hydrophilic Arg1 and C-terminal Ser-
Thr-Ile-Lys-Tyr sequence of KAMP-19, is equally active against
P. aeruginosa (Tam et al., 2012). KAMP-10 is also equally active
against P. aeruginosa. Since the structure is conserved in shorter
peptides such as KAMP-10 (Figure 3B), we propose the central
glycine-containing hydrophobic strip of KAMP-19 is critical for
membrane binding to inhibit this bacterium. This is consistent
with previous findings that glycine-to-alanine mutations (G6A
and G12A) in KAMP-10 significantly reduced its bactericidal
activity against P. aeruginosa (Tam et al., 2012). Such a mode of
membrane binding of KAMP peptides is different from canonical
amphipathic helices of human LL-37, where cationic side chains
can play an important role in membrane permeation (Wang,
2008; Wang et al., 2014).
KAMPs Induce Bacterial Cell Envelope
Damages in a Concentration-Dependent
Manner
KAMP-targeted bacterial cells appeared to have compromised
cell membrane integrity, and killing activity of KAMPs was rapid,
suggesting direct membrane perturbation might be involved in
their mechanism of action (Tam et al., 2012). To characterize
the ultrastructural changes in bacterial cell envelopes caused by
KAMPs, we used both SEM and TEM to directly observe two
clinically important pathogens, Gram-negative P. aeruginosa and
Gram-positive S. aureus, at high density (108 CFU/ml each in
saline) and treated with a bacteriostatic dose of KAMP-10 (45
µg/ml) and KAMP-18C (60 µg/ml) respectively. The bacterial
inhibition doses were defined as the concentrations at which no
bacterial growth was observed. Bacterial killing was verified by
the reduction of viable bacterial counts after 3 h of incubation
in 150 mM NaCl solution. The choice of KAMPs was based on
their activity spectra determined previously (Tam et al., 2012) and
the consideration that using those KAMPs with moderate activity
toward the two pathogens would allow us to detect subtle changes
in membrane integrity.
SEM and TEM showed that untreated P. aeruginosa
control cells were undergoing cell division and possessed
densely populated, membrane vesicle-like surface structures
(Figure 4A) as well as intact outer and cytoplasmic membranes
(Figures 4D,G). In contrast, P. aeruginosa treated with a
growth inhibitory concentration of KAMP-10 did not undergo
cell division and demonstrated partial loss of vesicle-like
surface structures (Figure 4B) and formation of pores on the
outer membrane (Figures 4E,H). These effects became more
severe when the concentration of KAMP-10 was increased to
bactericidal (60µg/ml). Treated P. aeruginosa showed substantial
loss of surface structures and peeled cell envelope (Figure 4C)
in addition to pore (channel-like) formation in outer and
cytoplasmic membranes, and in some cases complete membrane
disintegration (Figures 4F,I).
Similarly, Gram-positive S. aureus treated with a growth
inhibitory concentration of KAMP-18C showed deformed
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FIGURE 3 | NMR structures of KAMP-19 and KAMP-10 bound to SDS micelles at a peptide/SDS molar ratio of 1:60, pH 5.4 and 25◦C. (A) Well-resolved
NMR spectra of KAMP-19 (upper) and KAMP-10 (lower) indicated low randomness. (B) Hα secondary chemical shifts analysis of KAMP-19 (upper) and KAMP-10
(lower) in SDS micelles. (C) NMR structure of KAMP-19 bound to SDS micelles was refined. Superimposed backbone view of 10 structures of KAMP-19. The r.m.s.d.
for superimposing residues 2–18 is 0.57 Å. (D) Ribbon diagram of KAMP-19 with 310 helical turns between residues 7–9 and 15–17. (E) Stick view of the KAMP-19
structure with hydrophobic residues in green. (F) The same view as in (E) and the hydrophobic residues (green) are represented in the space filling model. In both (E)
and (F), hydrophilic side chains (in white, red, and blue) are limited to three regions in the view with a majority clustered at the C-terminus (red = oxygen and blue =
nitrogen). In addition, the aromatic ring of the C-terminal tyrosine can be seen to pack with the hydrophobic strip.
morphology of the cell envelope (Figure 5B) compared to
untreated control cells (Figure 5A). Using SEM, multiple
blisters were clearly visible on the surface of each bacterial
cell. Most of the blisters appeared to be open when the
concentration of KAMP-18C was increased to bactericidal
(150 µg/ml) (Figure 5C). In parallel, TEM of untreated S.
aureus showed intact and discrete cell walls and cytoplasmic
membranes (Figure 5D), whereas treated bacteria showed
irregular cytoplasmic retraction with cell wall detachment at
multiple locations in the cells (Figure 5E). The severity of cell
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FIGURE 4 | High-resolution (A–C) scanning and (D–I) transmission electron micrographs of P. aeruginosa (108 CFU/ml) treated with KAMP-10 in saline at 37◦C for
3 h. (A,D,G) Untreated control cells. (B,E,H) Cell treated with KAMP-10 at bacteriostatic concentration (45 µg/ml). Loss of bacterial surface vesicle-like components
was observed. Pores were mostly found on the bacterial outer membrane (arrows). (C,F,I) Cells treated with KAMP-10 at bactericidal concentration (60 µg/ml). The
cell envelope showed severe damages and peeling. More pores were formed and they penetrated both the outer and cytoplasmic membranes (arrows) leading to
leakage of cytoplasmic contents. Scale bar, 500 nm (A–C), 100 nm (D–F), 200 nm (G,H) or 500 nm (I).
envelope deformation and the appearance of discontinuous
cytoplasmic membranes were increasingly notable when
KAMP-18C was increased from bacteriostatic to bactericidal
concentration (Figure 5F).
Binding to LPS or LTA is not Required for
Antibacterial Action of KAMPs
Many AMPs are reported to bind endotoxins to gain access
to bacterial membranes and facilitate subsequent membrane
disruption or translocation into bacteria. To determine whether
the killing mechanism of KAMPs involves interactions with LPS
or LTA, we evaluated the binding affinities of KAMP-10 and
KAMP-19 to P. aeruginosa LPS and of KAMP-18C and KAMP-
36 to S. aureus LTA using a competitive binding assay, and
correlated the relative binding affinity with the killing activity.
This assay used a fluorescent probe, BODIPY-TR-cadaverine
(BC), which is quenched when bound to LPS or LTA, and
dequenched when competitively displaced and released from the
complex, as manifested by the increase of fluorescence detection
(Wood et al., 2004). Since binding affinities can be affected by
environmental factors, we conducted the assays in two vehicles
containing either sodium chloride or HEPES. The former is a
salt solution with intrinsic acidity (pH ∼5.5), and the latter is a
zwitterionic buffer at neutral pH (pH 7.5).
When compared with colistin, known to bind LPS and
LTA and interact with bacterial membranes to exert its killing
effect (100% fluorescent probe displacement), and meropenem,
an antibiotic that inhibits bacterial cell wall synthesis (0%
displacement), KAMP-10 and KAMP-19 showed up to 28.7 and
41% displacement respectively at 270 µM in 10 mM NaCl (p
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FIGURE 5 | High-resolution (A–C) scanning and (D–F) transmission electron micrographs of S. aureus (108 CFU/ml) treated with KAMP-18C in saline at 37◦C for
3 h. (A,D) Untreated control cells. (B,E) Cells treated with KAMP-18C at bacteriostatic concentration (60 µg/ml). Blisters (arrows) began to form on the cell surface.
The cytoplasmic membrane retracted from the cell wall. (C,F) Cells treated with KAMP-18C at bactericidal concentration (150µg/ml). Blisters were burst and holes
remained on the cell envelope. Spillage of cell contents was observed. More irregular membrane retractions were also found. Scale bar, 500 nm (A–C) or 100 nm
(D–F).
< 0.001 vs. colistin), indicative of relatively low affinities of
both peptides for P. aeruginosa LPS (Figure 6A). Nonetheless,
the peptides were highly effective at killing P. aeruginosa (near
100% cell death; p < 0.0001 vs. no peptide control in each
instance) (Figure 6B). When KAMP-10 or KAMP-19 was added
to BC:LPS complex in 5 mM HEPES buffer, neither peptide
displayed binding affinity for LPS (Figure 6A), however both
peptides remained highly active in killing P. aeruginosa (96.5 and
90.8% killing respectively, p < 0.0001 vs. no peptide control),
albeit their activities were reduced (p < 0.005) (Figure 6B).
The data suggested that interactions with LPS might enhance,
but were not required for bactericidal activity of KAMPs. This
observation is consistent with a previous report, which showed
that the bactericidal activity of KAMP-19 was not reduced by
LPS mutation (i.e., incomplete LPS core oligosaccharide and/or
O-antigen deficiency) in P. aeruginosa (Tam et al., 2012).
In the case of S. aureus LTA, as evident from Figure 6C, both
KAMP-18C and KAMP-36 showed low to moderate affinities in
HEPES buffer (up to 31.3 and 59.7% displacement respectively
at 270 µM, p < 0.005 vs. colistin). The affinities significantly
increased (up to 44.3% and 79.1% displacement respectively) in
NaCl solution (p < 0.05). While both KAMPs displayed lower
LTA binding affinities in HEPES than in NaCl solution, killing
activities were found to be similar for KAMP-18C or significantly
higher for KAMP-36 (65.3% killing in HEPES vs. 27.2% in saline,
p < 0.001) (Figure 6D). These data indicated that S. aureus
killing by KAMPswas not correlated with LTA binding. Similar to
anionic capsule polysaccharides produced by some bacteria that
limit the amount of antimicrobial peptides reaching their surface
(Llobet et al., 2008), LTA might be able to sequester KAMPs and
limit their access to the bacterial cell membrane.
Additional Interaction Partners of KAMPs
It is known that some AMPs have dual bactericidal mechanisms:
membrane disruption and inhibition of intracellular targets
(Wang et al., 2015). In addition, the bactericidal activity of
KAMPs against P. aeruginosa is not affected by high salt
concentration (150mM NaCl), suggesting that KAMPs might
directly interact with bacterial surface components. To identify
potential KAMP-interacting bacterial proteins, lysate fractions of
P. aeruginosa enriched with cytoplasmic proteins, periplasmic
proteins, outer membrane proteins or inner membrane proteins
were incubated with KAMP-19, and immunoprecipitated using
anti-KAMP-19 antibody-coupled resin. Mass spectrometry was
used to identify the proteins in the immunoprecipitates. The
relative quantity of identified proteins was indicated by spectral
counts (SC). Proteins with SC ≥ 10 were considered abundant.
Proteins that were much more abundant in the KAMP-19-
incubated bacterial fractions (IP) compared to the corresponding
no-peptide controls (i.e., those specifically pulled down by
KAMP-19) were considered as those with IP/control SC ratio
≥ 10. Using this method, we identified 9 abundant proteins
(SC ≥ 10) specifically bound to KAMP-19 (IP/control SC
ratio ≥ 10) (Table 2), including one outer membrane protein
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FIGURE 6 | Binding affinity of KAMPs to P. aeruginosa LPS or S. aureus LTA measured by the competitive binding assay. LPS- or LTA-bound BODIPY TR
cadaverine in 10mM NaCl or 5mM HEPES (pH 7.5) was competitively displaced by agents having affinity of LPS or LTA, resulting in increased fluorescence signal. (A)
KAMP-19 and KAMP-10 showed relatively low binding affinities to P. aeruginosa LPS in NaCl (left) and no binding in HEPES (right). (B) Using the same media, both
KAMPs were highly effective against P. aeruginosa. (C) KAMP-18C and KAMP-36 displayed lower binding affinities for LTA in HEPES compared with NaCl. However,
(D) these peptides showed similar (KAMP-18C) or stronger (KAMP-36) bactericidal activities in HEPES against S. aureus. Mean ± SD is shown. **p < 0.005, ***p <
0.001 (t-test, two-tailed).
(hypothetical protein PSPA7_4325), which is 99% identical
to the outer membrane lipoprotein SlyB of P. aeruginosa
strain PAO1, and one cytoplasmic membrane associated protein
- sodium-translocating NADH-quinone oxidoreductase (Na+-
NQR) subunit A (NqrA). The remaining seven are intracellular
proteins - recombinase A (RecA), ATP-dependent RNA helicase
(RhlE), ribosomal large subunit pseudouridine synthase B and
C (RluB and RluC), 30S ribosomal proteins S2 and S7, and 50S
ribosomal protein L14; all except RecA are involved in normal
ribosome assembly, stability and efficient protein synthesis.
DISCUSSION
Keratins are essential components of the epithelial cell
cytoskeleton. Previously, we reported that bactericidal
fragments of keratin 6A (KAMPs) have neutral or modest
positive charge and are expressed in stratified epithelial
cells, suggesting a novel, direct antimicrobial function for
keratins in epithelial innate defense against infection. The
current study characterized the 3D structure of KAMPs and
explored their mode of action at the bacterial membrane
interface. We show that micelle-bound KAMPs do not display
conventional α-helical or β-sheet structure. While they induce
ultrastructural damage to the bacterial cell envelopes, LPS
or LTA binding is not involved to facilitate their bactericidal
activity. We further identified a hypothetical lipoprotein
(PSPA7_4325) of P. aeruginosa as a potential outer membrane
target of KAMPs, and several other proteins, including
NqrA, a cytoplasmic membrane-bound respiratory enzyme
subunit, and the ribosome machine as potential intracellular
targets of KAMPs. These data shed light on the bactericidal
mechanism of this distinct family of epithelial-derived
AMPs.
AMPs are diverse, but can be classified into four unified
classes based on the types of secondary structures (Wang, 2010).
The first class is α-helical peptides; the second class consists of
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TABLE 2 | Mass spectrometry identified P. aeruginosa proteins co-immunoprecipitated with KAMP-19.
NCBI Accession Protein Category Molecular SC Counts SC ratio
weight (kDa) (IP/control)
IP Control
WP_003092260 Recombinase A (RecA) DNA repair 37 16 1 16.0
WP_017001581 ATP-dependent RNA helicase (RhlE) Ribosome assembly 70 10 1 10.0
WP_012075012 Hypothetical protein PSPA7_1951 (ortholog of Ribosomal
large subunit pseudouridine synthase B, RluB)
Ribosome assembly 44 16 0 IP only
WP_012075168 Ribosomal large subunit pseudouridine synthase C (RluC) Ribosome assembly 36 13 1 13.0
WP_003092394 30S ribosomal protein S2 Ribosome assembly 27 18 1 18.0
WP_003093742 30S ribosomal protein S7 Ribosome assembly 17 14 1 14.0
WP_003093714 50S ribosomal protein L14 Ribosome assembly 13 10 0 IP only
WP_003109479 Na+-translocating NADH-quinone oxidoreductase subunit A
(NqrA)
Ion pump 48 11 1 11.0
WP_012076740 Hypothetical protein PSPA7_4325 (ortholog of SlyB) Outer membrane lipoprotein 16 10 1 10.0
Proteins with both Spectral Count (SC) and Spectral Count Ratio (IP:control) ≥ 10 are shown.
β-sheet structures. While the αβ class contains both α and β
structures, the non-αβ class has neither α nor β structure. Indeed,
the majority of AMPs possess positive net charges and strong
helical and/or beta structures; anionic or neutral peptides or
those with low propensity to form defined secondary structures
are rarely reported. In humans, there are only three reported
classes of AMPs - α, β, and αβ - and until now there have been
no reports of human AMPs with a non-αβ structure (Wang,
2014). The most studied AMPs in humans, i.e., cathelicidin
(LL-37), α-defensins and β-defensins, are cationic and belong
to the α-helical, β-sheet, and αβ peptides respectively. Bovine
indolicidin, a 13-residue cationic AMP rich in tryptophan and
proline, has been themodel peptide representing the non-αβ class
for almost two decades since its NMR structure was determined
(Rozek et al., 2000). In the current study, we have identified
a non-αβ class of human AMPs, in which KAMP-19 and its
proteolytic variants do not contain regular α-helical structures
as observed in LL-37 or regular β-sheet structures as observed
in human α-defensins. KAMP-19, a glycine-rich peptide without
any tryptophan is distinct from the tryptophan-rich indolicidin
peptide. This non-αβNMR structure of KAMPs is consistent with
CD spectra, which do not suggest any regular α-helical or β-sheet
structure (Figures 1, 2). However, there are 310 helical turns and
bends in the structure that allow the KAMP peptide chain to
fold into a membrane-binding scaffold. The hydrophobic strip
(Figure 3) of the peptide binds to the P. aeruginosa inner and
outer membranes, and is therefore a unique addition to the
known 3D structures of human AMPs.
The mechanism of action of cationic helical/β-sheet AMPs
demonstrated that their initial binding to anionic bacterial
membrane is heavily dependent on electrostatic attractions,
and that their membrane perturbation activity requires defined
secondary structures in the bacterial membrane environment.
For example, basic Arg23 and hydrophobic phenylalanines of the
LL-37 major antimicrobial peptide directly interact with anionic
lipid phosphatidylglycerols, which are essential for perturbation
of the bacterial cell membrane (Wang, 2007; Wang et al.,
2014). However, the mechanism by which non-cationic, non-
αβ AMPs approach, bind and interact with bacterial membrane
remains unclear. Furthermore, many Gram-positive and -
negative bacteria have developed mechanisms to resist cationic
AMPs through reducing negative charge on the cell surface and
modifying membrane lipid composition (Nawrocki et al., 2014;
Band and Weiss, 2015). Non-cationic AMPs with low structural
requirement (high structural flexibility) for bactericidal activity
likely work together with cationic AMPs to generate an effective
innate defense system. These atypical AMPs and their derivatives,
including KAMPs described here, represent an underexplored
group of peptide-based anti-infective candidates that are worth
further investigation.
Specific interaction with the highly abundant, negatively
charged bacterial surface components, LPS and teichoic acids in
particular, is a key step for many cationic AMPs such as LL-
37 (Wang, 2008) prior to their subsequent actions to disrupt or
translocate across the membrane. As a result, bacterial mutants
with deficient, truncated or modified LPS or teichoic acids
can become resistant to these AMPs (Wang et al., 2014). For
example, Gram-negative Acinetobacter baumannii with adaptive
mutations in LPS biosynthesis genes (lpxA, lpxC, lpxD) or which
confer structural modifications of LPS lipid A (pmrA, pmrB)
are highly resistant to colistin, the cationic peptide antibiotic
that is the last resort treatment for multi-drug resistant bacteria
(Moffatt et al., 2010; Park et al., 2015). Also, Escherichia coli
and Salmonella typhimurium with waaY gene mutation that
affects heptose II phosphorylation of the LPS inner core have
decreased susceptibility to LL-37 (Lofton et al., 2013; Bociek et al.,
2015); D-alanylation of LTA catalyzed by the dlt operon enables
Group B Streptococcus resistance to cationic AMPs including
LL-37, magainin 2 and colistin (Saar-Dover et al., 2012). In
marked contrast, KAMP-10 and KAMP-19 interactions with any
of the three LPS components (O-antigen, core and lipid A) is
not required for bactericidal activity, suggesting that KAMPs
might have an advantage over the above classic cationic AMPs
to overcome this common resistance mechanism and remain
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effective against LPS mutants, and that those KAMPs might
be less likely to induce bacterial resistance that involves LPS
modification. However, as lipid A is known to activate TLR4-
mediated pro-inflammatory signaling cascade, the low binding
affinity of KAMP-10 and KAMP-19 for lipid A would be expected
to weaken their ability to neutralize LPS specifically through
the direct binding mode. Nevertheless, other mechanisms for
AMPs to modulate LPS-mediated inflammatory responses exist,
including competitive inhibition via TLR4/MD-2/CD14 receptor
binding (Nagaoka et al., 2001), inhibition of TLR4 endocytosis
and TRIF-dependent signaling (Shim et al., 2015), and perhaps
direct induction of anti-inflammatory gene expression through
other receptors. On the other hand, the relatively high binding
affinity of KAMP-18C and KAMP-36 for LTA, the Gram-
positive cell wall component that has endotoxin properties
similar to those of LPS, would likely correlate with their ability
to block LTA-induced inflammatory responses through direct
neutralization, as demonstrated previously for some AMPs (Scott
et al., 1999). Further studies are required to characterize the
interaction of KAMPs with LPS and LTA.
Increasing evidence has shown that binding to specific cell
surface receptors can facilitate the antimicrobial activity of
AMPs. For instance, hRNase7 binds to P. aeruginosa OprI
(outer membrane protein I) (Lin et al., 2010), and LL-37 to
Enterobacteriaceae Lpp (a major outer membrane lipoprotein)
(Chang et al., 2012) and A. baumannii OmpA (outer membrane
protein A) (Lin et al., 2015). In the current study, we identified
a potential P. aeruginosa surface receptor for KAMP-19. The
hypothetical protein PSPA7_4325 of P. aeruginosa strain 6206
is 99.4% homologous to the outer membrane lipoprotein SlyB
of another clinical isolate DK1. SlyB is well conserved in
Gram-negative bacteria and contributes to the integrity of cell
envelope (Plesa et al., 2006). Interestingly, expression of SlyB
can be upregulated by the PhoP-PhoQ system that is activated
under stressful conditions such as low magnesium (Perez et al.,
2009), low pH (Prost et al., 2007), or the presence of cationic
AMPs (Bader et al., 2005), i.e., those with high positive charge,
hydrophobicity and amphipathicity (Shprung et al., 2012). The
bacterial two-component system is also known to enable various
resistance mechanisms against cationic AMPs. If SlyB is shown
to facilitate the bactericidal activity of KAMPs, it would be of
interest to investigate further whether KAMPs are effective under
the conditions that are unfavorable to cationic AMPs, and to
examine if there is any synergism between KAMPs and other
cationic AMPs due to their activation of PhoPQ.
Using electron microscopy, we observed that KAMP-10
formed pores at the inner and outer membranes of P. aeruginosa.
The NMR structures of KAMP-19 and KAMP-10 provide a
basis for such interactions of the peptides with membranes.
Owing to the plasticity of the glycine strings, we speculate that
such a peptide structure may work equally well for KAMPs to
associate with variousmolecular partners. Our work suggests that
NqrA and the ribosomal machinery, among others, are potential
intracellular targets of KAMPs. NqrA is one of the six subunits
of Na+-NQR cytoplasmic membrane complex responsible for
generating the transmembrane electrochemical gradient of Na+
critical for virulence and survival of many pathogenic bacteria.
The bioenergetic sodium pump is not found in eukaryotes and
has been recognized as a potential target for new antibiotic
development (Dibrov, 2013). Structural characterization of Na+-
NQR complex revealed that NqrA is tightly bound to the
cytoplasmic side of NqrB that harbors the Na+ channel (Steuber
et al., 2015); therefore targeting NqrA might block the channel
entrance or alter the conformation of NqrB to block ion channel
activity. It is possible that KAMPs employ multiple antimicrobial
strategies from disrupting cell envelopes to inhibiting cellular
respiration and/or biosynthesis, which can make it more difficult
for bacteria to become resistant.
In conclusion, KAMP-19 and its proteolytic variants are the
first non-αβ antimicrobial peptides reported in humans. These
glycine-rich AMPs derived from epithelial keratin 6A have a
new amphipathic structure; the hydrophobic strip including
glycine residues is important for peptide-bacterial membrane
interactions. We show that these salt-tolerant peptides do
not require LPS and LTA binding for their initial access to
bacterial membranes; lipoprotein SlyB, highly conserved in
Gram-negative bacteria, might be the preferred dockingmolecule
on the outer membrane. We also demonstrate that KAMPs can
damage bacterial envelopes, and potentially target intracellular
machinery such as the respiratory sodium pump (Na+-NQR)
and the ribosomes. Further studies will be required to advance
our understanding of the modes of bactericidal action and to
determine if there are additional functions for KAMPs.While the
growth of knowledge about natural AMPs and the development
of synthetic anti-infective peptides are fueled by the studies
on canonical helices, this study highlights the first member for
a non-canonical class of human AMPs and may inspire new
designs of peptide-based antibiotics.
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